Our goal is to optimize the care for children diagnosed with a brain malformation/insult/injury, maximize neurodevelopment in early infancy and provide a smooth transition into adulthood.

Optimizing care for fetuses with potential neurologic diagnoses starts prenatally with a thorough evaluation and support of parents.

Brain development is one of the most complicated processes that occurs in utero. Our team is working to better understand how low oxygen levels affect brain development.

An inside look at our efforts to optimize and advance fetal neurologic care at Children's Hospital of Philadelphia.

Mitochondria are not "properly recycled" in some cases, and this may serve as a potential target for future therapeutic interventions.

For children under 5, a high fever can trigger a seizure. Find out how to identify a seizure and keep your child safe.

CHOP is the only center to capture standardized clinical data from ongoing patient care.

CHOP is one of 15 partner clinics chosen for their expertise at treating the neurodevelopmental disorder.

CHOP researchers were interviewed as a part of a comprehensive article about cell and gene therapy in Philadelphia Magazine.

The Friedreich’s Ataxia Center of Excellence at CHOP was awarded $1.275 million by the Friedreich’s Ataxia Research Alliance, Hamilton and Finneran families and the CureFA Foundation